Patents by Inventor Marc Pierre Lavergne

Marc Pierre Lavergne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzo[f]naphthyridine derivatives, their preparation and compositions containing them
    Patent number: 6566362
    Abstract: Benzo[f]naphthyridine derivatives of formula (I): benzo[f]naphthyridine derivatives and benzo[f]naphthyridine esters of formula (IVa): aminoquinoline derivatives of formula (X): processes for preparing such compounds; and compositions comprising them.
    Type: Grant
    Filed: December 31, 2001
    Date of Patent: May 20, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-François Desconclois, Arielle Genevois-Borella, Philippe Girard, Michel Kryvenko, Marc Pierre Lavergne, Jean-Luc Malleron, Guy Picaut, Michel Tabart, Sylvie Wentzler
  • Benzo[f]naphthyridine derivatives, their preparation and compositions containing them
    Publication number: 20020137741
    Abstract: Benzo[f]naphthyridine derivatives of formula (I): 1
    Type: Application
    Filed: December 31, 2001
    Publication date: September 26, 2002
    Inventors: Jean-Francois Desconclois, Arielle Genevois-Borella, Philippe Girard, Michel Kryvenko, Marc Pierre Lavergne, Jean-Luc Malleron, Guy Picaut, Michel Tabart, Sylvie Wentzler
  • Oxazole derivatives, their preparation and pharmaceutical compositions containing them
    Patent number: 5403852
    Abstract: Oxazole derivatives of the formula ##STR1## wherein R and R' are each hydrogen or alkyl containing 1 or 2 carbon atoms, R.sub.1 and R.sub.2 are the same or different and represent hydrogen, halogen or straight- or branched-chain (C.sub.1-4) alkyloxy radicals, and n is 3-6; their salts their isomers and mixtures and their preparation method, are method are described. These derivatives display anti-inflammatory activity.
    Type: Grant
    Filed: December 11, 1992
    Date of Patent: April 4, 1995
    Assignee: Laboratoire Roger Bellon
    Inventors: Michel Barreau, Michel Kryvenko, Marc-Pierre Lavergne, Auguste Techer